US anti-trust regulator FTC has passed its final order settling charges that Sun Pharma's USD 4 billion deal to acquire Ranbaxy Laboratories could result in unfair business practices. US anti-trust regulator FTC has passed its final order settling...
08.10 | 0
komentar | Read More